Abstract
Natural products have served humankind as drug leads for thousands of years. In the last century natural products have not only served as drugs but have inspired the generation of countless synthetic drugs and drug-leads around natural product pharmacophores. There are no disease targets for which natural products have played a more significant role than in the case of malaria and other parasitic diseases. In this review the significance of the manzamine class of marine alkaloids is presented as an example of the future utility of the oceans in the development of antiparasitics. The manzamines represent one of the few new structural classes identified in recent decades with potential for the control of malaria and tuberculosis. While considerable work remains to successfully optimize this class of drug-leads the novel pharmacophore and significant metabolic stability combined with a rapid onset of action and long half-life all strongly support further investigations of this group of potential drug candidates.
Keywords: Manzamine, Malaria, Marine Natural Products, Infectious Diseases
Current Pharmaceutical Design
Title: The Manzamines as an Example of the Unique Structural Classes Available for the Discovery and Optimization of Infectious Disease Controls Based on Marine Natural Products
Volume: 13 Issue: 6
Author(s): Mark T. Hamann
Affiliation:
Keywords: Manzamine, Malaria, Marine Natural Products, Infectious Diseases
Abstract: Natural products have served humankind as drug leads for thousands of years. In the last century natural products have not only served as drugs but have inspired the generation of countless synthetic drugs and drug-leads around natural product pharmacophores. There are no disease targets for which natural products have played a more significant role than in the case of malaria and other parasitic diseases. In this review the significance of the manzamine class of marine alkaloids is presented as an example of the future utility of the oceans in the development of antiparasitics. The manzamines represent one of the few new structural classes identified in recent decades with potential for the control of malaria and tuberculosis. While considerable work remains to successfully optimize this class of drug-leads the novel pharmacophore and significant metabolic stability combined with a rapid onset of action and long half-life all strongly support further investigations of this group of potential drug candidates.
Export Options
About this article
Cite this article as:
Hamann T. Mark, The Manzamines as an Example of the Unique Structural Classes Available for the Discovery and Optimization of Infectious Disease Controls Based on Marine Natural Products, Current Pharmaceutical Design 2007; 13 (6) . https://dx.doi.org/10.2174/138161207780162818
DOI https://dx.doi.org/10.2174/138161207780162818 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Enoyl ACP Reductase as Effective Target for the Synthesized Novel Antitubercular Drugs: A-State-of-the-Art
Mini-Reviews in Medicinal Chemistry Tuberculosis and Diabetes Mellitus in Northwest of Iran
Infectious Disorders - Drug Targets The Possible Potency of Ocimum basilicum New Constituent on Glucosestimulated Insulin Secretion In Vitro and β-cell Function In Vivo
Letters in Drug Design & Discovery Metabolic Imaging through Continuous In Situ Micro-extractions of Tissue Samples via Flowprobe Mass Spectrometry
Current Metabolomics The Importance of NAD in Multiple Sclerosis
Current Pharmaceutical Design Recent Advancements in Antimycobacterial and Antifungal Drugs: A Patent Perspective
Recent Patents on Biotechnology Other Activities
Current Bioactive Compounds Machine Learning and Social Network Analysis Applied to Alzheimer's Disease Biomarkers
Current Topics in Medicinal Chemistry Recent Advances in the Rational Drug Design Based on Multi-target Ligands
Current Medicinal Chemistry Clinical and Regulatory Status of Silymarin
Applied Drug Research, Clinical Trials and Regulatory Affairs Molecular Modeling Investigation of Some New 2-mercaptoimidazoles
Current Computer-Aided Drug Design Trends in Enzyme Inhibition and Activation in Drug Design - Part II
Current Topics in Medicinal Chemistry P2X7 1513 A>C Polymorphism Confers Increased Risk of Extrapulmonary Tuberculosis: A Meta-analysis of Case-Control Studies
Current Genomics Aspartic Peptidases of Human Pathogenic Trypanosomatids: Perspectives and Trends for Chemotherapy
Current Medicinal Chemistry Multi-Target-Directed Ligands as Innovative Tools to Combat Trypanosomatid Diseases
Current Topics in Medicinal Chemistry Therapeutic Options and Emerging Alternatives for Multidrug Resistant Staphylococcal Infections
Current Pharmaceutical Design Management of Adult Active Tuberculosis Disease in Era of HIV Pandemic, Current Practices and Future Perspectives
Infectious Disorders - Drug Targets Predicting the Impact of Antiretrovirals in Resource-Poor Settings: Preventing HIV Infections whilst Controlling Drug Resistance
Current Drug Targets - Infectious Disorders Drug Susceptibility Testing for Optimizing Tuberculosis Treatment
Current Pharmaceutical Design Repurposing of Fluvastatin Against Candida albicans CYP450 Lanosterol 14 α-demethylase, a Target Enzyme for Antifungal Therapy: An In silico and In vitro Study
Current Molecular Medicine